Bladder Cancer Tissue Study in Muscle-Invasive Patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been part of a specific prior study or be planning to have your bladder removed as part of standard care.
- You must have a type of bladder cancer called urothelial carcinoma (the most common kind).
- You must be in good general health (able to do daily activities with little or no help).
- Your cancer must have grown into the muscle layer of the bladder (stage T2, T3, or T4) and not have spread to lymph nodes or other organs.
- You must have tumor tissue and blood samples from the start of your treatment available for the study.
- You cannot be in this study if you refuse to take part in the linked trials or if your samples are not available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a standard chemotherapy given before surgery works for muscle-invasive bladder cancer. It aims to see if higher responses lead to better outcomes.
This study examines immune cells and tissue structure in bladder cancer samples from patients who had bladder removal surgery. Researchers hope to better understand how the immune system interacts with cancer tissue to improve future treatment strategies.
This trial tests whether using a patient's own tumor cells in lab-made clusters (PTCs) can help guide chemotherapy before bladder removal surgery for muscle-invasive bladder cancer. If you qualify, you'll receive personalized treatment followed by surgery.
This study uses a special PET/CT scan to see how far your bladder cancer has spread. The results may help doctors plan the best treatment for you.
This trial looks at how the immune environment around a muscle-invasive bladder tumor changes after you receive treatment before surgery (neoadjuvant therapy). The goal is to understand why some tumors respond better, which could help guide future treatments.
This trial tests if adding a special CT scan before bladder removal helps find muscle-invasive bladder cancer earlier. It includes people with different stages of bladder cancer who are planning to have their bladder removed.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.